Status:
RECRUITING
Magnetic Resonance & Optical Spectroscopy Validation
Lead Sponsor:
AdventHealth Translational Research Institute
Conditions:
Validation Studies
Magnetic Resonance Spectroscopy
Eligibility:
All Genders
18-89 years
Brief Summary
The purpose of this study is to develop and refine techniques for using magnetic resonance and optical spectroscopy to investigate how your body uses energy.
Detailed Description
Primary Study Objective: To evaluate the reproducibility of acquiring multi-nuclear data on a new 3T Philips Magnet in conjunction with Optical Spectroscopy.
Eligibility Criteria
Inclusion
- Male or female
- Age 18 - 89
- Healthy (self assessed)
- Weight under 350lbs
- Able to walk 50 yards without stopping
- Able to travel to hospital for study visits
- Able to follow a 3-step command
- Able to remain in magnetic resonance (MR) scanner for up to 2 hours
Exclusion
- Have internal metal medical devices, including cardiac pacemakers, aortic or cerebral aneurysm clips, artificial heart valves, ferromagnetic implants, shrapnel, wire sutures, joint replacements, bone or joint pins/rods/screws, metal fragments in your eye, or non-removable jewelry such as rings.
- Are unwilling or unable to complete the imaging procedures for the duration of the magnetic resonance imaging (MRI) scan due to claustrophobia or other reason.
- Serious mental illness that might preclude subject's ability to comply with study treatment
- Are pregnant or plan on becoming pregnant in the next 8 weeks.
- History of deep vein thrombosis (DVT) or pulmonary embolism (PE)
- Varicose Veins
- Known genetic factor (Factor V Leiden, etc.) or hypercoagulable state, including cancer, leukemia - such as chronic myelocytic leukemia (CML), hemoglobinopathies - such as sickle-cell disease and multiple myeloma and other proteinopathies.
- Diagnosed peripheral arterial or vascular disease
- Family history of primary DVT or PE
- Peripheral neuropathy
- History of chronic venous stasis or lower extremity edema
- Female taking hormonal birth control (oral or otherwise) AND smoker
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01827527
Start Date
March 1 2013
End Date
December 1 2025
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Translational Research Institute for Metabolism and Diabetes
Orlando, Florida, United States, 32804